← Back to Search

Spinal Cord Stimulation

Spinal Cord Stimulation Techniques for Chronic Pain

N/A
Waitlist Available
Led By Vafi Salmasi, MD.
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult English-speaking patient 18 years old or above
Persistent pain in lower back and/or leg for more than six months
Must not have
Patient refusal
Previous failed spinal cord stimulation trial with either high frequency or burst waveforms
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12, 24 and 36 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to compare the effectiveness of two different types of spinal cord stimulation in improving pain and function in patients with chronic back and/or leg pain.

Who is the study for?
This trial is for English-speaking adults over 18 with chronic lower back or leg pain lasting more than six months, who are recommended for spinal cord stimulation by Stanford's Pain Management Center. It excludes those who refuse to participate, have motor weakness in the lower body, or had a previous failed spinal cord stimulation trial.
What is being tested?
The study compares two types of spinal cord stimulations: high frequency and burst waveforms. It aims to determine which is more effective for long-term pain relief and function improvement in patients with chronic pain using an innovative data system called CHOIR.
What are the potential side effects?
While specific side effects are not listed here, typical risks of spinal cord stimulation can include infection at the implant site, bleeding, headache, allergic reaction to device materials, and temporary pain from the procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 or older and speak English.
Select...
I have had lower back or leg pain for over six months.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have chosen not to participate in the trial.
Select...
I have tried spinal cord stimulation without success.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12, 24 and 36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12, 24 and 36 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in pain intensity
Secondary study objectives
Anxiety
Depression
Function
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: High frequency spinal cord stimulationExperimental Treatment1 Intervention
Implant of the device that can deliver high frequency waveform to spinal cord
Group II: Burst spinal cord stimulationExperimental Treatment1 Intervention
Implant of the device that can deliver burst waveform to spinal cord

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,471 Previous Clinical Trials
17,501,838 Total Patients Enrolled
39 Trials studying Chronic Pain
9,334 Patients Enrolled for Chronic Pain
Vafi Salmasi, MD.Principal Investigator - Stanford University
Stanford University
1 Previous Clinical Trials
320 Total Patients Enrolled
1 Trials studying Chronic Pain
320 Patients Enrolled for Chronic Pain

Media Library

Burst spinal cord stimulation (Spinal Cord Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT03681262 — N/A
Chronic Pain Research Study Groups: High frequency spinal cord stimulation, Burst spinal cord stimulation
Chronic Pain Clinical Trial 2023: Burst spinal cord stimulation Highlights & Side Effects. Trial Name: NCT03681262 — N/A
Burst spinal cord stimulation (Spinal Cord Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03681262 — N/A
Chronic Pain Patient Testimony for trial: Trial Name: NCT03681262 — N/A
~26 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top